window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : June 9, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

pharmaceutical manufacturing

  • Biotech & Pharma Business,Drug Discovery & Development,Manufacturing & Supply Chain

    Lonza expands DNA-to-IND offering to accelerate biologics development timelines

    Lonza has expanded its integrated DNA-to-IND biologics development offering, introducing [...]

    June 8, 2026
  • Manufacturing & Supply Chain

    Ofichem unifies CDMO and pharmaceutical supply brands under single identity

    Ofichem has consolidated its multiple business units into a single [...]

    May 5, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development

    Research finds scientists view ELNs as ‘glorified filing cabinets’, driving duplication and shadow AI use

    A new survey by Sapio Sciences has found widespread frustration [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Manufacturing & Supply Chain

    Spore.Bio appoints Michael Miller as VP of scientific and regulatory affairs

    Spore.Bio has appointed Michael Miller as vp of scientific and [...]

    May 5, 2026
  • Drug Delivery & Formulation,Drug Discovery & Development,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    SGD Pharma leads pharma packaging innovation and decarbonisation at Pharmapack Europe 2026

    SGD Pharma, a global producer of pharmaceutical glass primary packaging, [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Manufacturing & Supply Chain

    Lonza to acquire Redberry to expand rapid microbiology testing for pharmaceutical quality control

    Lonza has signed an agreement to acquire Redberry, a French [...]

    May 5, 2026
  • Biotech & Pharma Business,Digital & Data,Manufacturing & Supply Chain

    Pharma leaders on AI, automation, and ESG: How CDMOs are reshaping development at CPHI Frankfurt 2025

    At another of this year’s CPHI Frankfurt 2025 roundtable, executives [...]

    May 5, 2026
  • Biotech & Pharma Business,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    Lonza appoints Jason Berndt as head of group operations and Maria Soler Nunez as chief quality officer

    Lonza has appointed Jason Berndt as head of group operations [...]

    May 5, 2026
  • Drug Delivery & Formulation,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    SGD Pharma to acquire Alphial to expand tubular glass and vial manufacturing in Europe

    SGD Pharma has signed an agreement with Italian private equity [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Drug Discovery & Development,Medical devices,Pharmaceuticals and therapeutics

    Robots could slash cost of cell therapy by 74%, opening doors to wider access

    Multiply Labs and Universal Robots pioneer automated manufacturing for personalised [...]

    May 5, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • LotusDx opens Aberdeen R&D laboratory to advance at-home STI testing
    Categories: Biotech & Pharma Business, Medical devices
  • Deep Science Ventures and Medicines Discovery Catapult target blood-brain barrier challenge
    Categories: Biotech & Pharma Business, Central Nervous System, Drug Discovery & Development
  • Phase 3 data support PSMA-targeted radiopharmaceutical combination approach in advanced prostate cancer
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top